Skip to content

As lawmakers wrangle over the debt ceiling, CNBC’s Jim Cramer spoke Monday to put faith in defensive stocks like health care, discount stores and natural gas.

Kramer in 2010 He looked to the debt ceiling crisis of 2011 for guidance, although history seems to be repeating itself.

“You don’t want losers turning into winners at this point. You want winners who have been winners in the ugly debt ceiling talks,” Cramer said. “If the talks break down at this point, you can bet that the focus will be on uncertainty, credit risks and recession, just as we worried about in the 2011 recession.”

Cramer pointed to natural gas pipeline company Oneok, which announced a $19 billion merger with Magellan Midstream Petroleum. Although Oneok was down more than 5% as of Monday’s close following the merger, Cramer called the deal a “match made in heaven.” In the year He cited Oneok’s success in 2011 when stocks did well amid uncertainty over the debt ceiling.

In the way of consumer-focused defense stocks, Cramer pointed to Chipotle as a safe bet. The restaurant chain recently reported a successful quarter and the stock had a good 2011.

“Chipotle trades wrong sometimes, but the best time to buy is when you have the most up-to-date information and the current information is fresher than Al Pastor,” Cramer said.

He suggested keeping an eye on apparel discounters Ross Stores and TJX, both of which are set to release earnings reports this week.

In addition, Kramer advised that pharmaceutical companies Biogen and Eli Lilly are aggressively pushing drugs to fight Alzheimer’s disease. But Kramer said he feels Eli Lilly has a slight edge because of the popular weight loss and diabetes drug Mounjaro, which he calls a “wonder drug.”

“I wish I hadn’t doubted that the theoretical debt ceiling negotiations would fall through or be imperfectly assembled,” Cramer said. “Take these current deals with what we know from the history of 2011 and you’ll be ready for anything this time throws at you. Doubt is not good.”

Register now For CNBC’s Invest Club, Jim Cramer follows each on the market.

Disclaimer: The CNBC Invest Club philanthropy owns shares of TJX and Eli Lilly.

[ad_2]

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *